Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    0.00 (0.00%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.51m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Deferred Consideration and Board Change

26 Mar 2018 07:00

RNS Number : 8338I
Mercia Technologies PLC
26 March 2018
 

RNS

26 March 2018

 

Mercia Technologies PLC("Mercia" or the "Group")

Deferred Consideration and Board Change

 

Mercia Technologies PLC (AIM: MERC), the national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions, is pleased to announce the full payment of the deferred consideration for the acquisition of Enterprise Ventures Group Limited ("Enterprise Ventures"), details of which were originally announced on 10 March 2016. The trigger for the payment of the £2.0million deferred consideration target (adjusted to £1.98million to take into account one Enterprise Ventures Seller ceasing to be an employee of the Group) was Enterprise Ventures successfully being awarded at least £80.0million in net new fund mandates during the two-year period following Mercia's acquisition. In fact, Enterprise Ventures has significantly outperformed this target, having been awarded £178.0million in net new fund mandates during this period, which is a very positive outcome for Mercia.

 

Mercia has deducted, and will settle, the Sellers' income tax and employees' national insurance liabilities arising from the receipt of the deferred consideration. The net deferred consideration is being settled by the issue of 2,707,475 Ordinary shares (the "Deferred Consideration Shares"). The value of each Deferred Consideration Share is 39.9 pence and is based on the average closing mid-market price for the five days ended 23 March 2018.

 

Application has been made for the Deferred Consideration Shares to be admitted to trading on the AIM market of the London Stock Exchange ("Admission") and it is expected that Admission will become effective at 8.00 a.m. on 29 March 2018. The Sellers include two Persons Discharging Managerial Responsibilities ("PDMRs").

 

Following Admission, Julian Viggars and John Simpson (both PDMRs) will hold the following Ordinary shares and options:

 

PDMR

Deferred Consideration Shares

Total number of Ordinary shares

Number of options over Ordinary shares

Julian Viggars

231,004

424,325*

400,000

John Simpson

481,317

754,997

250,000

 

*Including 75,000 Ordinary shares held by Mrs Emma Viggars

 

Following Admission, the Company will have 303,309,707 Ordinary shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Mercia under the FCA's Disclosure Guidance and Transparency Rules.

 

Board Change

 

Mercia Technologies also announces that following the wholly successful integration of Enterprise Ventures, Jonathan Diggines, its former Chief Executive, who joined the Board of Mercia as an Executive Director upon completion of the acquisition, has notified Mercia that he believes that this is the right time for him to relinquish his Mercia directorships. He will continue to work with the team at Mercia Fund Managers, the Group's growing and profitable fund management business, by participating in the investment decision-making process as a member of Mercia's numerous funds' Investment Committees. In particular, he will chair the new £45.1million Enterprise Ventures Growth II fund, which closed in December 2017.

 

Dr Mark Payton, CEO of Mercia Technologies PLC, said:

 

"Today's announcement of the significant overachievement of the Enterprise Ventures' deferred consideration target is another milestone in Mercia's evolution and demonstrates the Group's ability to identify, evaluate, price, acquire and successfully integrate value-adding acquisitions.

 

"I would like to take this opportunity to thank Jonathan Diggines for his significant personal contribution towards achieving the successful integration of Enterprise Ventures into the Group, where it has continued to flourish and grow. Jonathan's continuing involvement within Mercia can only be a catalyst for further investment success in the future."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information, please contact

Mercia Technologies PLC

+44 (0)330 223 1430

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.merciatech.co.uk

Cenkos Securities plc

+44 (0)20 7397 8900

Stephen Keys, Camilla Hume (NOMAD and Joint Broker)

Canaccord Genuity Limited

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel (Joint Broker)

Buchanan

+44 (0)20 7466 5000

Bobby Morse, Chris Lane, Stephanie Watson

www.buchanan.uk.com

About Mercia Technologies PLC

Mercia is a national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions. Mercia benefits from 19 university partnerships and offices across the Midlands, the North of England and Scotland providing it with access to high quality, regional deal flow. Mercia Technologies PLC is quoted on AIM with the epic "MERC".

 

Mercia's 'Complete Capital Solution' initially nurtures businesses via its third party funds (now with circa £350.0million under management following recent mandate wins) and then over time Mercia can provide further funding to its 'Emerging Stars' by deploying direct investment follow-on capital from its own balance sheet. Since its IPO in December 2014, Mercia has invested over £46.0million directly across its portfolio of 'Emerging Stars'.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUPAWUPRGMW
Date   Source Headline
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board
11th Oct 20167:00 amRNSDigital & Digital Entertainment Portfolio Update
5th Oct 20167:00 amRNSCapital Markets Event
27th Sep 20167:00 amRNSInvestment into innovative healthcare - Medherant
19th Sep 201610:36 amRNSResult of AGM
26th Aug 20167:00 amRNSDirector/PDMR Shareholdings
29th Jul 20167:00 amRNSPublication of Annual Report
28th Jul 20167:00 amRNSGrant Options & PDMR Dealings
26th Jul 20168:30 amRNSRe. Admission to AIM of Concepta PLC
21st Jul 20167:00 amRNSnDreams launches The Assembly for Oculus RIFT
7th Jul 20167:00 amRNSAcquisition, Placing & Open Offer, Change of Name
7th Jul 20167:00 amRNSFundraising & AIM Admission of Direct Investment
30th Jun 20167:00 amRNSPreliminary Results
20th Jun 20167:00 amRNSFour New University Partnerships
1st Jun 20167:00 amRNSNotice of Preliminary Results
26th May 20167:00 amRNSBoard Changes
20th May 20167:00 amRNSMercia's nDreams signs Google VR app deal
9th May 20167:00 amRNSFirst Direct Investment via Enterprise Ventures
17th Mar 20163:30 pmRNSNotification of Major Interest in Shares
17th Mar 20167:00 amRNSNew Direct Investment
10th Mar 20167:02 amRNSAcquisition of Enterprise Ventures
21st Jan 20167:00 amRNSNotice of Mercia Fund Management AGM
15th Dec 20157:00 amRNSThree additional university partnerships

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.